Clinical Trial

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

Study acronym: Hypo-Combi
Unknown Phase 1/2
View on ClinicalTrials.gov →
Summary
Hypo-Combi Trial: A Prospective Phase I/II Study of Combined Hypofractionated External Beam Radiation Therapy (EBRT) plus Interstitial High-Dose-Rate Brachytherapy (HDR-BT) for Intermediate/High Risk Prostate Cancer
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05003752
Lead Sponsor German Oncology Center, Cyprus
Conditions Prostate Adenocarcinoma, Radiation Toxicity
Enrollment 40 participants
Start Date 2021-08-01
Primary Completion 2022-12-31 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2023-03-07